Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
$86.28
Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
31 Oct 2025, 11:49
Chart & Data from IG
Palantir is set to report its latest earnings today after the market closes, and investors are closely watching for any surprises.
Currently, Palantir shares are trading at $81.01, with an extremely high price-to-earnings (P/E) ratio of 417 and a forward P/E of 176. Compared to its industry peers and the broader market, these valuations suggest that Palantir may be significantly overvalued.
With such high expectations already priced in, any earnings disappointment could trigger heightened volatility over the next few days.
From a technical standpoint, Palantir’s stock is testing major resistance levels:
Both the Relative Strength Index (RSI) and Williams %R indicators suggest that Palantir stock is in overbought territory, adding downward pressure heading into earnings.
While optimism remains ahead of Palantir’s earnings, the stock’s high valuation, key resistance levels, and overbought indicators suggest a high-risk, high-reward setup. Traders and investors should remain cautious as volatility is likely to spike following the earnings release.